文献速递神经MR

联合T1对比增强脑灌注成像与磁敏感加权定量成像鉴别II/III级与IV级胶质瘤

Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
PubMed 文献 · Neuroradiology · 2017-10-31

本研究纳入129例胶质瘤患者(IV级70例、III级33例、II级26例),用T1灌注MRI测rCBV、SWI测ITSS评分,比较不同级别间差异。结果显示IV级rCBV显著高于III级、III级显著高于II级(p<0.001);IV级ITSS显著高于III级(p<0.001),III级与II级ITSS无显著差异;联合rCBV与ITSS可显著提高III级与IV级的鉴别能力。

要点

  • IV级胶质瘤rCBV显著高于III级,III级显著高于II级(p<0.001)。
  • IV级胶质瘤SWI的ITSS评分显著高于III级(p<0.001)。
  • III级与II级间ITSS评分无显著差异。

核心结论

  • 联合T1灌注MRI衍生的rCBV值与SWI衍生的ITSS评分可提高鉴别III级与IV级胶质瘤的诊断准确性。

研究设计与样本

  • 研究纳入129例胶质瘤患者(IV级70例、III级33例、II级26例),采用T1灌注MRI测量rCBV、SWI测量ITSS评分,比较II级与III级、III级与IV级、III+II级与IV级肿瘤间的差异。

关键影像表现/征象

  • IV级胶质瘤rCBV值显著高于III级,III级显著高于II级(p<0.001)。
  • IV级胶质瘤SWI的ITSS评分显著高于III级(p<0.001)。
  • III级与II级胶质瘤的ITSS评分比较无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: MRI is a useful method for discriminating low- and high-grade glioma using perfusion MRI and susceptibility-weighted imaging (SWI). The purpose of this study is to evaluate the usefulness of T1-perfusion MRI and SWI in discriminating among grade II, III, and IV gliomas.

METHODS: T1-perfusion MRI was used to measure relative cerebral blood volume (rCBV) in 129 patients with glioma (70 grade IV, 33 grade III, and 26 grade II tumors). SWI was also used to measure the intratumoral susceptibility signal intensity (ITSS) scores for each tumor in these patients. rCBV and ITSS values were compared to seek differences between grade II vs. grade III, grade III vs. grade IV, and grade III+II vs. grade IV tumors.

RESULTS: Significant differences in rCBV values of the three grades of the tumors were noted and pairwise comparisons showed significantly higher rCBV values in grade IV tumors as compared to grade III tumors, and similarly increased rCBV was seen in the grade III tumors as compared to grade II tumors (p < 0.001). Grade IV gliomas showed significantly higher ITSS scores on SWI as compared to grade III tumors (p < 0.001) whereas insignificant difference was seen on comparing ITSS scores of grade III with grade II tumors. Combining the rCBV and ITSS resulted in significant improvement in the discrimination of grade III from grade IV tumors.

CONCLUSION: The combination of rCBV values derived from T1-perfusion MRI and SWI derived ITSS scores improves the diagnostic accuracy for discrimination of grade III from grade IV gliomas.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Saini J, Gupta PK, Sahoo P, et al. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging. Neuroradiology. 2017. PMID: 29090331. doi:10.1007/s00234-017-1942-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。